Sutro Biopharma, Inc. (STRO) is a publicly traded Healthcare sector company. As of August 7, 2026, STRO trades at $22.90 with a market cap of $415.92M and a P/E ratio of -0.99. STRO moved -5.17% today. Year to date, STRO is +120.35%; over the trailing twelve months it is +195.34%. Its 52-week range spans $5.23 to $43.85. Analyst consensus is strong buy with an average price target of $52.60. Rallies surfaces STRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for STRO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $22.90 |
| Market Cap | $415.92M |
| P/E Ratio | -0.99 |
| EPS | $-24.53 |
| Dividend Yield | 0.00% |
| 52-Week High | $43.85 |
| 52-Week Low | $5.23 |
| Volume | 118 |
| Avg Volume | 0 |
| Revenue (TTM) | $99.61M |
| Net Income | $-153.60M |
| Gross Margin | 0.00% |
8 analysts cover STRO: 0 strong buy, 7 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $52.60.